So, did tramadol users feel better? Not enough. The combined results showed a slight reduction in pain, but the change wasn’t big enough to make a real difference in daily life. In other words, most patients might not notice enough improvement to justify staying on the medication.
Serious and Mild Side Effects Are a Real Concern
What did stand out was the risk. Eight trials that monitored side effects found tramadol roughly doubled the risk of serious health issues compared to a placebo, predominantly heart-related episodes like chest pain and heart failure. Milder problems—including nausea, dizziness, constipation, and sleepiness—were also more common in tramadol users.
Opioid Dangers Go Beyond Just Tramadol
The review puts tramadol’s risks into the wider context of the global opioid crisis. With millions worldwide struggling with opioid addiction and opioid-related deaths on the rise—rising from nearly 50,000 deaths in the U.S. in 2019 to over 81,000 in 2022—the call to limit opioid use, including tramadol, has never been louder.
Study Limitations and What You Should Know
Researchers admit that many of the trials they reviewed had potential bias, likely exaggerating tramadol’s benefits and underplaying its risks. All things considered, they advise that tramadol’s slight pain relief doesn’t outweigh its potential harms.
Bottom Line
If you are managing chronic pain, talk to your healthcare provider about alternative treatments. This new review suggests that, for most people, tramadol’s modest benefits aren’t worth the serious health risks.
Continue reading by clicking the ( NEXT 》 ) button below !
